Plain-English translation of NCT07118098 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is looking for early warning signs of type 1 diabetes in people who are related to or close friends with someone who has the disease. Researchers will take a small blood sample from you to check for special markers called autoantibodies — these are signs that your immune system may be attacking the cells that make insulin, even before you feel sick. If you have these markers, the research team will follow up with you to monitor your health.
Type 1 diabetes can develop quietly over months or years before symptoms show up. By finding people with early warning signs now, doctors may be able to help prevent or delay the disease, and researchers can learn more about how it develops.
You likely qualify if…
You likely don't qualify if…
You will have a small blood sample taken, which will be tested for autoantibodies. If your results are negative (no markers found), you will not need any further involvement. If your results are positive, a member of the research team will contact you to discuss your results and may invite you for additional monitoring or follow-up visits.
AI-generated summary from trial data · Jul 14, 2026 · Not medical advice
Austria
Belgium
Czechia
France